Loading clinical trials…
Loading clinical trials…
Clinical trials · failure tracking
Oncology studies whose overall status is TERMINATED, WITHDRAWN or SUSPENDED on ClinicalTrials.gov, with the stop reason exactly as the registrant posted it. A category is attached only when an explicit keyword rule matches the text; CancerIndex never infers why a study stopped.
380 stopped studies mapped to Malignant Uterine Neoplasm and descendants · 86% state a reason
Over the 380 studies matching the cancer, status and year filters (the category filter does not change this chart). Each study is counted once, in the first matching category; greyed bars are studies whose text matched no rule or was empty.
Computedrules ci-stop-reasons-v1 · keyword matching only
A category is assigned when one of its keywords appears in the posted text (case-insensitive, whole words). Rules are tested in this order and the first match wins; every match is kept in the API (reasonMatches).
| NCT | Title | Phase | Status | First posted | Lead sponsor | Why stopped (as posted) | Category |
|---|---|---|---|---|---|---|---|
| NCT00003179 | Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer | Phase 2 | terminated | Jan 27, 2003 | Gynecologic Oncology Group | not stated | Not stated |
| NCT00002976 | Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer | Phase 3 | terminated | Jan 27, 2003 | Gynecologic Oncology Group | not stated | Not stated |
| NCT00003624 | Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine,… | Phase 2 | terminated | Jun 16, 2004 | Gynecologic Oncology Group | not stated | Not stated |
| NCT00006224 | Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix | Phase 2 | terminated | Nov 11, 2003 | Gynecologic Oncology Group | not stated | Not stated |
| NCT00006482 | Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the… | Phase 2 | terminated | Oct 8, 2003 | Gynecologic Oncology Group | not stated | Not stated |
| NCT00016341 | Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With… | Phase 3 | terminated | Sep 9, 2003 | Gynecologic Oncology Group | not stated | Not stated |
| NCT00030472 | Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the… | Phase 2 | terminated | Jan 27, 2003 | Gynecologic Oncology Group | not stated | Not stated |
| NCT00054067 | Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With… | Phase 3 | terminated | Feb 6, 2003 | Gynecologic Oncology Group | not stated | Not stated |
| NCT00005808 | Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical… | Phase 1 | terminated | Jan 27, 2003 | National Cancer Institute (NCI) | Administratively complete. | Other (stated, no rule matched) |
| NCT00002796 | Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced… | Phase 1 / Phase 2 | terminated | Jan 27, 2003 | National Cancer Institute (NCI) | Administratively complete. | Other (stated, no rule matched) |
| NCT00137358 | Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer | Phase 1 | withdrawn | Aug 29, 2005 | University of Alabama at Birmingham | unable to obtain funding to conduct study | Funding |
| NCT00052585 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent… | Phase 2 | terminated | Jan 27, 2003 | National Cancer Institute (NCI) | Administratively complete. | Other (stated, no rule matched) |
| NCT00087191 | EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or… | N/A | terminated | Jul 12, 2004 | National Cancer Institute (NCI) | Administratively complete. | Other (stated, no rule matched) |
| NCT00669422 | ChemoFx® PRO - A Post-Market Data Collection Study | — | terminated | Apr 30, 2008 | Precision Therapeutics | not stated | Not stated |
| NCT00496080 | Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding(DUAO) | N/A | terminated | Jul 4, 2007 | Ethicon, Inc. | Trial terminated early due to results from a similar study. | Other (stated, no rule matched) |
| NCT01290406 | BEZ235 Trial in Patients With Advanced Endometrial Carcinoma | Phase 2 | withdrawn | Feb 7, 2011 | Novartis Pharmaceuticals | not stated | Not stated |
| NCT00057928 | S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or… | Phase 3 | withdrawn | Apr 9, 2003 | SWOG Cancer Research Network | lack of accrual | Enrollment / accrual |
| NCT01313104 | Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With… | N/A | withdrawn | Mar 11, 2011 | Northwestern University | Lack of funding | Funding |
| NCT00231829 | A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers | Phase 2 | terminated | Oct 4, 2005 | Mark H. Einstein | Due to reported toxicity of Celecoxib at high doses | Safety / toxicity |
| NCT00118300 | Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical… | Phase 1 | withdrawn | Jul 11, 2005 | Case Comprehensive Cancer Center | Competing studies | Other (stated, no rule matched) |
| NCT01363466 | Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer | Phase 3 | terminated | Jun 1, 2011 | UNICANCER | low recruitment | Enrollment / accrual |
| NCT00496067 | Uterine Artery Occlusion for Fibroid Related Bleeding | N/A | terminated | Jul 4, 2007 | Ethicon, Inc. | Data required further pilot work to be undertaken. | Other (stated, no rule matched) |
| NCT00629993 | Dissemination of Cervical Cancer Screening to Primary Care Physicians in Underserved… | Phase 4 | terminated | Mar 6, 2008 | Columbia University | Principal Investigator left the institution | Investigator |
| NCT01140555 | A Pilot Study to Determine Optimal Procedure Steps to Obtain and Maintain Uterine Artery… | N/A | terminated | Jun 9, 2010 | Ethicon, Inc. | Further internal evaluation of the device was required. | Other (stated, no rule matched) |
| NCT00161226 | A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for… | — | terminated | Sep 12, 2005 | University of Medicine and Dentistry of New Jersey | Principal investigator left institution | Investigator |
| NCT00921635 | A Study to Evaluate the Impact of Maintaining Hemoglobin Levels in Anemic Patients With…(HOSTT) | Phase 3 | suspended | Jun 16, 2009 | Tri-Service General Hospital (TSGH) | not stated | Not stated |
| NCT00584207 | Radiofrequency Ablation of Uterine Fibroids | Early Phase 1 | terminated | Jan 2, 2008 | University of California, Davis | Unsufficient referrals for recruitment | Enrollment / accrual |
| NCT00451945 | New Indications for Ultrasound in the Staging of Cervical Cancer | N/A | withdrawn | Mar 26, 2007 | Rigshospitalet, Denmark | not stated | Not stated |
| NCT00106262 | Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer | Phase 2 | terminated | Mar 22, 2005 | Women and Infants Hospital of Rhode Island | Lack of accrual | Enrollment / accrual |
| NCT00220532 | Folate and Protection Against Cervical Cancer | Phase 1 / Phase 2 | terminated | Sep 22, 2005 | Sheffield Teaching Hospitals NHS Foundation Trust | not stated | Not stated |
Stop reasons are registrant-reported free text and are displayed verbatim (truncated; hover for the full text). Categories come from explicit keyword rules and are never inferred from the study design, sponsor or outcome; a study that stopped for several reasons is filed under the first rule that matched. A TERMINATED status does not imply a negative result.
Data updated 23 days agoSource updated Jun 10, 2013source: clinicaltrials